Coloplast A/S 11/5/2024 Earnings Report

Coloplast A/S EPS Results

• Actual EPS: $0.08
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Coloplast A/S Revenue Results

• Actual Revenue: $1.02 billion
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Coloplast A/S Announcement Details

• Date: 11/5/2024
• Time: N/A
• Conference Call Date: N/A
• Conference Call Time: N/A

Coloplast A/S (OTCMKTS:CLPBY) is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste. The continence care segment offers catheters, drainage bags and related supplies for individuals with bladder control issues. The company’s wound and skin care portfolio includes advanced dressings, negative-pressure wound therapy and pressure ulcer prevention products, while its interventional urology line features devices for minimally invasive procedures and diagnostics in urological conditions.

Founded in 1957 by Danish entrepreneur Aage Louis-Hansen, Coloplast began when Louis-Hansen developed the first adhesive ostomy bag to help his wife manage her postoperative care. Since then, the company has grown from a small family operation into a publicly listed corporation on the Copenhagen Stock Exchange, with an American depositary receipt program trading under the symbol CLPBY in the U.S. The company is led by President and CEO Peter Clemmensen, who has overseen continued expansion of R&D and manufacturing capabilities.

Headquartered in Humlebæk, Denmark, Coloplast operates manufacturing and research facilities across Europe and North America, supported by a global sales and distribution network. Its products are available in more than 100 countries, with regional offices and partnerships that ensure local market support and training for healthcare professionals. The company places a strong emphasis on customer proximity and collaborative development to address the evolving needs of patients and clinicians worldwide.